NCT06267105 A Clinical Study to Compare Functional Outcomes After Surgery Using a Transverse or Longitudinal Surgical Incision in the Skin.
| NCT ID | NCT06267105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Corporacion Parc Tauli |
| Condition | Functional Disturbance as Result |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-05-15 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-05-15 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Trigger finger is a common pathology in the hand. Patients suffer from pain and depending on which tasks, patients have difficulty to perform them. Its treatment in initial and less serious phases includes conservative measures, but failure of these may require releasing the trigger finger with surgery. The surgical technique performed for trigger finger is the opening of the A1 pulley, the skin incisions used for this surgery are various (transverse, longitudinal, oblique). Trigger finger surgery presents good results in terms of resolution, but complications may also occur. The reason for this study is to assess whether there are functional differences using the Dash scale when we perform a transverse or longitudinal incision in trigger finger surgery.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age. * Clinical diagnosis of trigger finger grade II to IV. Grade I (pre-trigger) Pain, history of entrapment, but not demonstrable on physical examination, tenderness over the A1 pulley. Grade II (active) Demonstrable entrapment, but the patient can actively extend the finger. Grade III (passive) Demonstrable entrapment, patient requires passive extension IIIA or inability to actively flex IIIB. Grade IV (contracture) Demonstrable entrapment with fixed flexion contracture of the PIP. Exclusion Criteria: * Thumb * Polydigital * Allergy to local anesthetics and/or vasoconstrictor agents. * Previous surgery * Patients who, in the researcher's opinion, are not good candidates for the study (e.g. inability to comply with the follow-up program, comorbidity, poor physical or mental health in general, drug or alcohol abuse problems...).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06267105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Functional Disturbance as Result. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06267105 currently recruiting?
Yes, NCT06267105 is actively recruiting participants. Contact the research team at mmvinas@tauli.cat for enrollment information.
Where is the NCT06267105 trial being conducted?
This trial is being conducted at Sabadell, Spain.
Who is sponsoring the NCT06267105 clinical trial?
NCT06267105 is sponsored by Corporacion Parc Tauli. The trial plans to enroll 36 participants.